Race Oncology Ltd. (AU:RAC) has released an update.
Race Oncology Ltd has announced the application for quotation of new securities on the ASX, with a total of 13,533 ordinary fully paid shares to be quoted under the code RAC. The announcement, dated June 27, 2024, marks a new development for the biotechnology firm, which specializes in cancer therapeutics.
For further insights into AU:RAC stock, check out TipRanks’ Stock Analysis page.
